PMID: 9545022Apr 17, 1998Paper

Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats

Obesity Research
H R DavisM Van Heek

Abstract

Glucagon-like peptide (7-36) amide (GLP-1) acutely inhibits food and water consumption in rats after intracerebroventricular (icv) administration. To assess the potential for desensitization of these effects, we investigated the effects of chronic icv administration of GLP-1 on food consumption and body weight in Sprague-Dawley (SD) rats and Zucker (fa/fa) obese rats. In vitro functional densensitization of the GLP-1 receptor was not observed after overnight exposure of Rin m5F insulinoma cells to GLP-1 at concentrations up to 10 nM. Administration of GLP-1 to SD rats (30 microg icv twice a day for 6 days) resulted in significant reductions in 24-hour food consumption each day (25 +/- 1%). Continuous icv infusion of GLP-1 for 7 and 14 days significantly inhibited cumulative food consumption and reduced body weight in SD rats. In the genetically obese Zucker rat, chronic dosing with GLP-1 (30 microg icv) once a day for 6 days caused significant reductions in food consumption each day and a reduction in body weight. These results indicate that the GLP-1 pathways in the central nervous system controlling food consumption do not desensitize after chronic exposure to GLP-1 and suggest that agonists of the central GLP-1 receptor may ...Continue Reading

References

Jan 1, 1991·Comparative Biochemistry and Physiology. A, Comparative Physiology·R Schnitzer-PolokoffR Burrier
Jan 1, 1986·Journal of Neuroscience Research·V K HanP K Lund
Apr 1, 1988·Brain Research·R M GubitsR Simantov
Jan 1, 1995·The Journal of Clinical Investigation·Z WangS R Bloom
May 1, 1995·Diabetes Care·P J Lefèbvre
May 1, 1996·Biochemical Society Transactions·I GunnS R Bloom
Nov 1, 1996·Endocrinology·P J ShughrueI Merchenthaler
Jan 16, 1997·Nature·G van DijkI L Bernstein

❮ Previous
Next ❯

Citations

Jan 22, 2003·Physiology & Behavior·Ewa Bojanowska, Bozena Stempniak
Apr 24, 2001·Pharmacology & Therapeutics·J C ClaphamM Tadayyon
Apr 21, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S D PrimeauxG A Bray
Oct 23, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Elisabeth L RaabRebecca A Simmons
Mar 12, 2004·Expert Opinion on Investigational Drugs·Torsten P Vahl, David A D'Alessio
Jan 3, 2016·Psychoneuroendocrinology·Rozita H AnderbergKarolina P Skibicka
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·Kiwon BanMansoor Husain
Mar 18, 2009·Regulatory Peptides·Dong-Hoon KimRandy J Seeley
Dec 3, 2015·Canadian Journal of Physiology and Pharmacology·Vishal PatelMukul R Jain
Jul 11, 2006·Physiology & Behavior·Christoph Beglinger, Lukas Degen
Feb 21, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·D K Arulmozhi, B Portha
Jul 29, 2004·Nutritional Neuroscience·Iwona BogackaRoy J Martin
Jun 14, 2014·Biochimica Et Biophysica Acta·Takafumi HaraAkira Hirasawa
Sep 30, 2003·Diabetes Care·Daniel J Drucker
Dec 22, 2011·Journal of Nutrition and Metabolism·D El KhouryG H Anderson
Nov 25, 2004·The Annals of Pharmacotherapy·Scott V JoyAnn C Scates
Nov 24, 2011·Diabetes & Metabolism Journal·Ji Sung Yoon, Hyoung Woo Lee
Feb 19, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Prasanth K ChelikaniRoger D Reidelberger
Sep 27, 2005·Physiological Reviews·Sarah StanleyStephen Bloom
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Sep 19, 2019·Nutrition & Metabolism·Cesar Miguel Momesso Dos SantosRenata Gorjão
Aug 16, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·E E DanielT J McDonald
Aug 26, 2009·Journal of Medicinal Chemistry·Claudio MapelliWilliam R Ewing
Dec 25, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Vishal PatelMukul Jain
May 4, 2004·Annales d'endocrinologie·T J Kieffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.